Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177

Detalles Bibliográficos
Autores principales: Jäger, Niklas, Hoffmann, Markus, Pöhlmann, Stefan, Krüger, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324898/
https://www.ncbi.nlm.nih.gov/pubmed/35891506
http://dx.doi.org/10.3390/v14071526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324898/
https://www.ncbi.nlm.nih.gov/pubmed/35891506
http://dx.doi.org/10.3390/v14071526

Ejemplares similares